SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program

GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology

Through strategic collaboration with GenScript ProBio, Initium Therapeutics plans to utilize GenScript ProBio’s Berkeley Lights Beacon platform to expand their antibody drug pipeline.

Serving a Rising Power

GenScript ProBio Chinese Brand Unveiled, CDMO Capacity Upgraded

GenScript ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPAC

GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program

GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.

GenScript ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processes

Beroni Group Signs Agreement with GenScript ProBio to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

GenScript launches CDMO segment GenScript ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

GenScript and Selecxine Enter Into Strategic Cooperation Agreement

China's Largest Plasmid and Virus Facility from GenScript was Put into Operation

GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma

GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation

Chinese CDMO GenScript starts construction of GenScript-Legend Biotech Commercial Manufacturing Center